BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28799787)

  • 1. Increased Risk of Diabetes Among 6-24-Year-Olds Using Second Generation Antipsychotics.
    Xing S; Lee TA
    J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):782-791. PubMed ID: 28799787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Diabetes Hospitalization or Diabetes Drug Intensification in Patients With Depression and Diabetes Using Second-Generation Antipsychotics Compared to Other Depression Therapies.
    Xing S; Kim S; Schumock GT; Touchette DR; Calip GS; Leow AD; Lee TA
    Prim Care Companion CNS Disord; 2018 May; 20(3):. PubMed ID: 29873957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths.
    Rubin DM; Kreider AR; Matone M; Huang YS; Feudtner C; Ross ME; Localio AR
    JAMA Pediatr; 2015 Apr; 169(4):e150285. PubMed ID: 25844991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.
    Xing S; Calip GS; Leow AD; Kim S; Schumock GT; Touchette DR; Lee TA
    J Diabetes Complications; 2018 May; 32(5):492-500. PubMed ID: 29544744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of type 2 diabetes among patients exposed to the combination of pravastatin and paroxetine.
    Gooden KM; Bibeau KB; Wood J; Irizarry MC; Pan X; Allen J; Sampson T; Heim JM
    Curr Drug Saf; 2015; 10(2):152-8. PubMed ID: 24861991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotic initiation and the risk of type II diabetes in children and adolescents.
    Sohn M; Talbert J; Blumenschein K; Moga DC
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):583-91. PubMed ID: 25808613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth in the concurrent use of antipsychotics with other psychotropic medications in Medicaid-enrolled children.
    Kreider AR; Matone M; Bellonci C; dosReis S; Feudtner C; Huang YS; Localio R; Rubin DM
    J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):960-970.e2. PubMed ID: 25151419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic medication use among children and risk of diabetes mellitus.
    Andrade SE; Lo JC; Roblin D; Fouayzi H; Connor DF; Penfold RB; Chandra M; Reed G; Gurwitz JH
    Pediatrics; 2011 Dec; 128(6):1135-41. PubMed ID: 22106077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the risk of type 2 diabetes mellitus among children and adolescents with psychiatric disorders treated with atypical antipsychotics: a population-based nested case-control study.
    Lee H; Song DH; Kwon JW; Han E; Chang MJ; Kang HY
    Eur Child Adolesc Psychiatry; 2018 Oct; 27(10):1321-1334. PubMed ID: 29460164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.
    Bobo WV; Cooper WO; Stein CM; Olfson M; Graham D; Daugherty J; Fuchs DC; Ray WA
    JAMA Psychiatry; 2013 Oct; 70(10):1067-75. PubMed ID: 23965896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patients.
    Gibson TB; Jing Y; Kim E; Bagalman E; Wang S; Whitehead R; Tran QV; Doshi JA
    Manag Care; 2010 Aug; 19(8):40-7. PubMed ID: 20822071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus.
    Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
    J Am Acad Child Adolesc Psychiatry; 2017 Aug; 56(8):642-651. PubMed ID: 28735693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic Medication Use in Children and Adolescents With Type 1 Diabetes.
    Liu S; Lagerberg T; Ludvigsson JF; Taylor MJ; Chang Z; D'Onofrio BM; Larsson H; Lichtenstein P; Gudbjörnsdottir S; Kuja-Halkola R; Butwicka A
    JAMA Netw Open; 2023 Oct; 6(10):e2336621. PubMed ID: 37787995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.
    Mehta S; Johnson ML; Chen H; Aparasu RR
    J Clin Psychiatry; 2010 Jun; 71(6):689-98. PubMed ID: 20573328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RISK OF NEW ONSET TYPE II DM IN MDD PATIENTS RECEIVING SECOND-GENERATION ANTIPSYCHOTICS TREATMENT: A NATIONWIDE COHORT STUDY.
    Lin CY; Wu YH; Wang HS; Chen PK; Lin YF; Chien IC
    Depress Anxiety; 2016 May; 33(5):435-43. PubMed ID: 26990119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database.
    Fife D; Blacketer C; Knight K; Weaver J
    Drugs Real World Outcomes; 2021 Dec; 8(4):481-496. PubMed ID: 34109564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study.
    Mamakou V; Hackinger S; Zengini E; Tsompanaki E; Marouli E; Serafetinidis I; Prins B; Karabela A; Glezou E; Southam L; Rayner NW; Kuchenbaecker K; Lamnissou K; Kontaxakis V; Dedoussis G; Gonidakis F; Thanopoulou A; Tentolouris N; Zeggini E
    BMC Psychiatry; 2018 Aug; 18(1):249. PubMed ID: 30071838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic drugs and risk of burn injury in individuals with mental illness: a 10-year population-based case-control study.
    Chang CM; Wu KY; Chiu YW; Wu HT; Tsai YT; Chau YL; Tsai HJ
    Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):918-27. PubMed ID: 27476980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes.
    Morrato EH; Newcomer JW; Kamat S; Baser O; Harnett J; Cuffel B
    Diabetes Care; 2009 Jun; 32(6):1037-42. PubMed ID: 19244091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of manic switch associated with antidepressant therapy in pediatric bipolar depression.
    Bhowmik D; Aparasu RR; Rajan SS; Sherer JT; Ochoa-Perez M; Chen H
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):551-61. PubMed ID: 25470655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.